This study contributes to the existing literature by identifying THBS1 and the JAK2/STAT3 pathway as promising molecular targets for therapeutic intervention in RILI-associated fibrosis, offering a feasible mechanistic basis for future antifibrotic strategies. This evidence concerns the gene JAK2 and fibrosis.